Mode
Text Size
Log in / Sign up

Low inferior mesenteric artery ligation does not significantly impact survival in rectosigmoid cancer patientsSurgery Technique Comparison Shows Similar Outcomes for Rectosigmoid Cancer

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that low and high inferior mesenteric artery ligation show no significant difference in survival for rectosigmoid cancer.

This meta-analysis evaluated the impact of surgical technique on outcomes for 1152 patients with rectosigmoid cancer. The study compared low inferior mesenteric artery ligation (LL) to high inferior mesenteric artery ligation (HL) over a 60.0 month follow-up period. The primary outcomes of interest were 5-year overall survival (OS) and disease-free survival (DFS).

Analysis of primary outcomes showed a 1.40 months difference in OS (95% c.i. -0.18 to 2.98) and a 0.71 months difference in DFS (95% c.i. -1.55 to 3.03). Neither difference reached statistical significance. Secondary outcomes, including anastomotic leak (RR 0.71) and overall complications (RR 0.79), were reported as comparable between the two groups. Other secondary metrics, such as the total number of lymph nodes retrieved (SMD 0.01) and operating time (SMD 0.08), also showed comparable results.

There is a moderate level of certainty regarding the findings for OS and DFS. The study did not detect a statistically significant difference in 5-year OS and DFS between LL and HL. Clinical application of these findings should consider the moderate certainty of the evidence and the lack of statistically significant differences in primary survival outcomes.

Researchers analyzed data from 1,152 patients with rectosigmoid cancer who underwent surgery. The study compared two specific surgical techniques: low inferior mesenteric artery ligation (LL) and high inferior mesenteric artery ligation (HL). The goal was to see if one method provided better long-term results for patients.

The findings showed that both surgical methods resulted in similar outcomes. There was no statistically significant difference in overall survival or disease-free survival over a 60-month period. Additionally, the rates of complications, such as anastomotic leaks, and the number of lymph nodes retrieved were comparable between the two groups.

Because the results were similar, this suggests that both surgical approaches are currently comparable for these patients. However, because this was a meta-analysis with a moderate level of certainty for survival data, these results should be discussed with a surgical team to determine the best approach for an individual case.

What this means for you:
Two different artery ligation techniques show similar survival rates and complication risks for rectosigmoid cancer.

Common questions

Are there significant differences in survival between the two surgical methods?

The study found no statistically significant difference in 5-year overall survival or disease-free survival between the low and high artery ligation methods. The difference in overall survival was only 1.40 months, and the difference in disease-free survival was 0.71 months, meaning both methods performed similarly over the 60-month follow-up period.

Are there different risk levels for complications between these techniques?

The results showed that complications were comparable between the two methods. Specifically, the risk ratio for anastomotic leaks was 0.71 and the risk ratio for overall complications was 0.79. These figures suggest that both surgical techniques have similar safety profiles regarding common complications.

How does the surgical time or lymph node count differ between the methods?

The study found that the total number of lymph nodes retrieved and the total operating time were comparable between the two methods. The standardized mean difference for lymph nodes was 0.01 and for operating time was 0.08, indicating that the two techniques did not differ significantly in these areas.

Study Details

Study typeMeta analysis
Sample sizen = 1,152
EvidenceLevel 1
Follow-up60.0 mo
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: The optimal level of inferior mesenteric artery ligation in rectosigmoid cancer surgery remains a matter of debate. This study evaluated the prognostic impact of low ligation (LL) versus high ligation (HL) after rectal or sigmoid cancer resection. METHODS: A reconstructed individual patient data meta-analysis of randomized clinical trials (RCTs) was performed using restricted mean survival time difference (RMSTD) estimation. PubMed, MEDLINE, Scopus, Web of Science, ClinicalTrials.gov, Cochrane Central Library, and Google Scholar were searched. Primary outcomes were 5-year overall (OS) and disease-free survival (DFS). The RMSTD, risk ratio (RR), standardized mean difference (SMD), and 95% confidence interval (c.i.) were used as pooled effect size measures. The certainty of evidence was categorized with the GRADE framework. RESULTS: Overall, 1152 patients from five RCTs were included; 34% underwent LL. Baseline demographics and pathological tumour stage were balanced among the LL and HL groups. At the 60-month follow-up, the OS and DFS estimates for LL versus HL were 1.40 months (95% c.i. -0.18 to 2.98; moderate level of certainty) and 0.71 months (95% c.i. -1.55 to 3.03; moderate level of certainty). Anastomotic leak (RR 0.71), overall complications (RR 0.79), total number of lymph nodes retrieved (SMD 0.01), and operating time (SMD 0.08) were comparable. CONCLUSION: This meta-analysis did not detect a statistically significant difference in 5-year OS and DFS between LL and HL in patients with rectosigmoid cancer.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.